Collisions of Value

Tuesday, October 9; 3 PM – 4 PM
Moderator: Jeff Champagne, Director, Business Development, MPR Product Development

The concept of creating “collisions of value” is about high-potential start-up companies interacting with valuable partners along their journey. These companies could be large strategic partners, payers, OEMs, investors and more. “Collisions of value” can be planned or serendipitous.

Planned collisions include a formal email introduction or a business development director reaching out to mentor a start-up on how to get funded. It could be a start-up’s presentation to an industry group that sparks interest from a scout sitting in the audience.

Serendipitous collisions are similar interactions that happen more by chance — not by luck. This type of collision happens by putting yourself in the right place at the right time, and being fortunate enough to meet a new mentor or potential investor. Participating in an industry event where the world’s experts in a niche market gather, listening to a few of them speak, and then introducing your start-up to the speaker to get their reaction to the value propositions you are building into your business model is a great way to sharpen an entrepreneur’s tools.

Serendipity is an important ingredient in the success of any new technology’s path to market. There is an air of collaboration in the Boston Healthcare Ecosystem that is unique. Everyone is willing to make an introduction to a friend that needs help, an executive looking for that next role in their career, or investor who is searching for that next shiny new development project to get behind. Mentorship is an active and free-flowing currency in Cambridge. From lunch and learns to pitch competitions, and industry events, there is no shortage of high value events to fill your calendar. I would argue that this constant buzz of activities and chance encounters are just as important to the ecosystem’s success as are the many prestigious academic institutions and hospitals that call Boston home. From breakfast in the President’s Box at Fenway Park to a lunch Pitch Competition at the Harvard Club to dinner at Dean Kamen’s house, we have been immersed in this ecosphere for the last 10 years and there has never been a better time for Innovation in Boston than right now. Look at the last 3 quarters of investment in Medtech. Let’s look at some of the ingredients that make this such a special place. There are plenty of opportunities during this two-part panel session and pitch round, BHA, MEDTECH, ARMI, MPR and M2D2 will provide real-world examples of how these “collisions” have resulted in mutually beneficial partnerships from executives themselves. You will hear best practices on how to navigate a partnership from both the big- and small-company perspective from some of the people who have successfully executed these agreements.

Then, in part two, start-ups will present elevator pitches specifically aimed at creating partnerships with strategic investors.

Companies Pitching include
1. Purple Sun
2. Dynocardia
3. 149 Medical
4. Vitascan
5. Ms. United